the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Homebuyers claims tribunal, Strata Management Tribunal settled 51,233 cases from 2018 to 2023 – KPKT

PUTRAJAYA: The Local Housing and Government Ministry (KPKT), through the Tribunal for Homebuyers Claims (HCT) and the Strata Management Tribunal (SMT), successfully resolved 51,233 cases, including pending cases, from 2018 to 2023.

The ministry said in a statement today that the HCT handled 9,081 cases while the SMT handled 42,152 cases.

“The highest number of resolutions was in 2023, with 11,361 cases, and HCT resolved 943 cases from January to May this year, with 791 cases registered in the same period.

“There were 4,180 registered cases with the SMT, with 3,927 cases resolved in the same period,” the ministry added.

Meanwhile, Local Housing and Government Minister Nga Kor Ming presented appointment letters to 28 new presidents for both tribunals today.

“The appointed presidents must always ensure their own image and give full commitment in carrying out their duties justly, transparently and with integrity.

“With these appointments, it is hoped that tribunal hearings will run smoother and more efficiently as well as meet set targets,” Nga said.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Portugal defeat Croatia 2-1 to reach World Cup last 16

Portugal's forward #07 Cristiano Ronaldo celebrates after scoring his team's first goal from the penalty spot during the 2026 World Cup round of 32 football match between Portugal and Croatia at the Toronto Stadium in Toronto on July 2, 2026. (Photo by Cole Burston / AFP)

Addressing medical inflation

Consumers are struggling as medical insurance premiums surge, with over 340,000 dropping coverage amid calls for price regulation and stronger public healthcare

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings